Curasight investor relations material

Listen to the latest call from Curasight

Curasight is a clinical stage biopharmaceutical company dedicated to developing uPAR Theranostics for the early detection, diagnosis and treatment of cancer. The company's mission is to make a global impact by harnessing imaging technology that improves diagnosis and correlates to improved long-term patient outcome.

Dig deeper into the Curasight fundamentals on Quartr.